“…We discovered that that EGR1 was targeted by 53 TFs (ex; LMO2); DDX5 was targeted by 51 TFs (ex; MYCN); NCOA3 was targeted by 48 TFs (ex; SIN3B); STAT1 was targeted by 42 TFs (ex; IRF8); HIF1A was targeted by 40 TFs (ex; GATA1); RPS14 was targeted by 45 TFs (ex; RCOR3); RPL3 was targeted by 44 TFs (ex; DMRT1); RPS19 was targeted by 42 TFs (ex; GCH1 [81], LYST (lysosomal trafficking regulator) [82], PELI1 [83], EGR1 [84], SNX10 [85], CA2 [86], ZEB2 [87], HIF1A [88], PLA2G7 [89] [105], NFIA (nuclear factor I A) [106], CCR7 [107], PRDX2 [108], ADK (adenosine kinase) [109], TCF7 [110], LGALS3 [111], OLFM2 [112], HDAC11 [113] and ARPC1B [114] are significantly related to the atherosclerosis. Studies have revealed that KCNJ2 [115], TLR4 [116], JAK2 [117], TLR2 [118], EGR1 [119], GAB1 [120], ZBTB11 [121], BIN1 [122], TCF4 [123], PPP1R13L [124], TRPM4 [125], LGALS3 [126] and SNTA1 [127] plays a key role in cardiac arrhythmia. Recently, increasing evidence demonstrated that KCNJ2 [128], TLR4 [129], CYP2D6 [130], TLR2 [129], SNX10 [131], SIRT1 [132], PF4 [133], PCYT2 [134] and LGALS3 [135] were altered expression in atrial fibrillation.…”